The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial

Table 1 Patient demographic and clinical characteristics.

* Although patients had, on average, 3 adequate antidepressant trials (see ^f) many also received antidepressants at lower dosages than those described below.
^fTherapeutically recommended daily doses were; venlafaxine, 225 mg/350 mg (moderate, severe depression, respectively), citalopram 40 mg, sertraline 200 mg, mirtazapine 45 mg, nefazodone 600 mg, paroxetine 50 mg, amitriptyline 300 mg, phenelzine 90 mg [17, 18].
** With either lithium carbonate or an atypical antipsychotic.
*** Electroconvulsive therapy.

ISSN: 1471-244X